These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 414622)

  • 41. Delayed hemolytic transfusion reaction due to anti-Go(a), an antibody against the low-prevalence Gonzales antigen.
    Larson PJ; Lukas MB; Friedman DF; Manno CS
    Am J Hematol; 1996 Dec; 53(4):248-50. PubMed ID: 8948664
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Failure to develop anti-D antibodies following unintentional immunization of a patient with an O Rh(-) blood group with blood belonging to the A Rh(+) group after surgery for ectopic pregnancy].
    Konieczny H; Wysocki R
    Wiad Lek; 1976 Oct; 29(20):1869-72. PubMed ID: 826022
    [No Abstract]   [Full Text] [Related]  

  • 43. Do you think that the cross match with donor red cells can be omitted when the serum of a patient has been tested for the presence of red cell alloantibodies with a cell panel?
    Vox Sang; 1982; 43(3):151-68. PubMed ID: 6815895
    [No Abstract]   [Full Text] [Related]  

  • 44. Blood groups and transfusions.
    Campbell J
    Prof Nurse; 1996 Oct; 12(1):39-40, 43-4. PubMed ID: 9128648
    [No Abstract]   [Full Text] [Related]  

  • 45. Actual possiblities of prophylaxis of rhesus iso-immunization.
    Breborowicz H; Gerwelowa H; Krawczyńska Z; Gruszczyńska J; Baraniecka K; Karowa L
    Pol Med J; 1969; 8(3):736-40. PubMed ID: 4980000
    [No Abstract]   [Full Text] [Related]  

  • 46. Red cell alloantibodies in patients with haemoglobinopathies.
    Hmida S; Mojaat N; Maamar M; Bejaoui M; Mediouni M; Boukef K
    Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):363-6. PubMed ID: 7892131
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Securing of blood group serological identity in blood transfusions].
    Heiss F; Giese R
    Munch Med Wochenschr; 1966 Jan; 108(3):175-7. PubMed ID: 4962713
    [No Abstract]   [Full Text] [Related]  

  • 48. [Prevention of sensitization of Rh-negative women with anti-D sera and anti-D globulins].
    Preisler O; Schneider J
    Bibl Gynaecol; 1966; 38():1-22. PubMed ID: 4957982
    [No Abstract]   [Full Text] [Related]  

  • 49. [HEMOLYTIC COMPLICATION IN BLOOD TRANSFUSION CAUSED BY AN ANTIBODY IN THE LEWIS BLOOD GROUP].
    DUEH A; HORVATH E; NEMAK P; SIMON A; BAJTAI G; KEREKES E
    Orv Hetil; 1963 Sep; 104():1737-40. PubMed ID: 14090020
    [No Abstract]   [Full Text] [Related]  

  • 50. Analysis of RhCE variants among 806 individuals in France: considerations for transfusion safety, with emphasis on patients with sickle cell disease.
    Pham BN; Peyrard T; Juszczak G; Beolet M; Deram G; Martin-Blanc S; Dubeaux I; Roussel M; Kappler-Gratias S; Gien D; Poupel S; Rouger P; Le Pennec PY
    Transfusion; 2011 Jun; 51(6):1249-60. PubMed ID: 21166680
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Post-transfusion alloimmunization in patients with sickle cell disease.
    Orlina AR; Unger PJ; Koshy M
    Am J Hematol; 1978; 5(2):101-6. PubMed ID: 104621
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A blood transfusion hazard.
    Dickson DN; Wilkinson R
    S Afr Med J; 1977 Oct; 52(15):592. PubMed ID: 411185
    [No Abstract]   [Full Text] [Related]  

  • 53. Problems in transfusion therapy.
    Charache S
    N Engl J Med; 1990 Jun; 322(23):1666-8. PubMed ID: 2342526
    [No Abstract]   [Full Text] [Related]  

  • 54. THE INCREASING IMPORTANCE OF ISOIMMUNISATION IN BLOOD TRANSFUSION PRACTICE.
    SHAW AE; PHIBBS JD; ALBREY JA; MCCULLOCH WJ
    Bibl Haematol; 1964; 19():622-5. PubMed ID: 14267081
    [No Abstract]   [Full Text] [Related]  

  • 55. Anti-U recognizing a variant of the U-blood group.
    Mentor J; Richards HS
    Vox Sang; 1989; 56(1):62. PubMed ID: 2492702
    [No Abstract]   [Full Text] [Related]  

  • 56. [Immune antibodies and acute renal failure (author's transl)].
    Luboldt W; Heimsoth VH
    Dtsch Med Wochenschr; 1974 Nov; 99(46):2340-3. PubMed ID: 4214689
    [No Abstract]   [Full Text] [Related]  

  • 57. Temporary suppression of Lewis blood-group antibodies.
    Rickard KA; Worlledge SM
    Lancet; 1968 Aug; 2(7565):456. PubMed ID: 4174176
    [No Abstract]   [Full Text] [Related]  

  • 58. Immunosuppressive therapy in Rh-incompatible transfusion.
    Eklund J; Nevanlinna HR
    Br Med J; 1971 Sep; 3(5775):623-4. PubMed ID: 4105610
    [No Abstract]   [Full Text] [Related]  

  • 59. [Modification of the test for Rh-factor compatibility using heparinized polyglucin].
    Uspenskaia OV; Neupokoeva EA
    Probl Gematol Pereliv Krovi; 1970 Nov; 15(11):56-9. PubMed ID: 4993147
    [No Abstract]   [Full Text] [Related]  

  • 60. Lewis incompatibility.
    Perkins HA; Mallory D; Bergren M; Frank B
    Transfusion; 1982; 22(4):346. PubMed ID: 7101434
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.